Form 4 for RGNX REGENXBIO Inc.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001562180-24-004656 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-04 | 2024-05-31 | RGNX | Zachary Jennifer | Dir | A - Grant | $0.00 | +4,790 | 14.3K | +50% | $0 |
| D | 2024-06-04 | 2024-05-31 | RGNX | Zachary Jennifer | Dir | A - Grant | $0.00 | +24.5K | 24.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | A | A | 4,790 | $0.00 | 14,296 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer. |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-05-31 | A | A | 24,454 | $0.00 | 24,454 | D | $14.35 · — to 2034-05-31 | 24,454 Common Stock | (F2) The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer. |